SPARC shares price: Sun Pharma Advanced Research Company stocks experienced a sharp drop of over 18% on Wednesday after its experimental drug SCD-044, which was being tested to treat moderate to severe psoriasis and atopic dermatitis (eczema), failed to deliver the desired results